Functional conservation of the malaria vaccine antigen MSP-119 across distantly related Plasmodium species

Nature Medicine

Volumn 6, Issue 1, 2000, Pages 91-95

  O'Donnell, Rebecca A ^a   Saul, Allan ^b   Cowman, Alan F ^c   Crabb, Brendan S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MALARIA VACCINE; MEMBRANE PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CHIMERA; ERYTHROCYTE; MALARIA; MEROZOITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ERYTHROCYTES; MALARIA VACCINES; MEROZOITE SURFACE PROTEIN 1; MOLECULAR SEQUENCE DATA; PLASMODIUM; PLASMODIUM FALCIPARUM; PYRIMETHAMINE; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

PLASMODIUM CHABAUDI; PLASMODIUM FALCIPARUM; PROTOZOA; RODENTIA;

EID: 0033958230     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/71595     Document Type: Article

References (20)

1. Egan, A.F. et al. Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J. Infect. Dis. 173, 765-769 (1996).
2. Blackman, M.J., Heidrich, H.-G., Donachie, S., McBride, J.S. & Holder, A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red blood cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172, 379-382 (1990).
3. Chang, S.P. et al. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype. J. Immunol. 152, 3483-3490 (1994).
4. Egan, A., Burghaus, P., Druilhe, P., Holder, A. & Riley, E. Human antibodies to the 19kDa C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 inhibit parasite growth in vitro. Parasite Immunol. 21, 133-139 (1999).
5. Daly, T.M. & Long, C.A. A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice. Infect. Immun. 61, 2462-2467 (1993).
6. Ling, I.T., Ogun, S.A. & Holder, A.A. Immunization against malaria with a recombinant protein. Parasite Immunol. 16, 63-67 (1994).
7. Rotman, H.L., Daly, T.M. & Long, C.A. Plasmodium: Immunization with carboxyl terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp. Parasitol. 91, 78-85 (1999).
8. Perera, K.L., Handunnetti, S.M., Holm, I., Longacre, S. & Mendis, K. Baculovirus merozoite surface protein 1 C-terminal recombinant antigens are highly protective in a natural primate model for human Plasmodium vivax malaria. Infect. Immun. 66, 1500-1506 (1998).
9. Kang, Y. & Long, C.A. Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol. Biochem. Parasitol. 73, 103-110 (1995).
10. Miller, L.H., Roberts, T., Shahabuddin, M. & McCutchan, T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59, 1-14 (1993).
11. Qari, S.H. et al. Predicted and observed alleles of Plasmodium falciparum merozoite surface protein-1 (MSP-1), a potential malaria vaccine antigen. Mol. Biochem. Parasitol 92, 241-252 (1998).
12. Blackman, M.J., Scott Finnigan, T.J., Shai, S. & Holder, A.A. Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein. J. Exp. Med. 180, 389-393 (1994).
13. Cooper, J.A., Cooper, L.T. & Saul, A.J. Mapping of the region predominantly recognized by antibodies to the Plasmodium falciparum merozoite surface antigen MSA 1. Mol. Biochem. Parasitol. 51, 301-312 (1992).
14. Chitarra, V., Holm, I., Bentley, G., Petres, S. & Longacre, S. The crystal structure of the C-terminal merozoite protein 1 at 1.8Å resolution, a highly protective malaria vaccine candidate. Mol. Cell. 3, 457-464 (1999).
15. Morgan, W. et al. Solution structure of the EGF module pair from the Plasmodium falciparum merozoite surface protein 1. J. Mol. Biol. 289, 113-122 (1999).
16. Egan, A.F. et al. Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP-1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparum. Infect. Immun. 63, 456-466 (1995).
17. Egan, A., Waterfall, M., Pinder, M., Holder, A. & Riley, E. Characterization of human T- and B-cell epitopes in the C terminus of Plasmodium falciparum merozoite surface protein 1: evidence for poor T-cell recognition of polypeptides with numerous disulfide bonds Infect. Immun. 65, 3024-3051 (1997).
18. Patino, J.A., Holder, A.A., McBride, J.S. & Blackman, M.J. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies. J. Exp. Med. 186, 1689-1699 (1997).
19. Crabb, B.S., Triglia, T., Waterkeyn, J. & Cowman, A.F. Stable transgene gene expression in Plasmodium falciparum. Mol. Biochem Parasitol. 90, 131-144 (1997).
20. Crabb, B.S. & Cowman, A.F. Characterization of promoters and stable transfection by homologous and nonhomologous recombination in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 93, 7289-7294 (1996).